Abstracts tagged "depression"

Abstract Number: 2437 • ACR Convergence 2025
Bupropion for Lupus-Induced Fatigue Treatment (B-LIFT): A Retrospective Analysis
Aaron Smith¹, Thuyvan Phan², Leah Luizza³, Anthony Trujillo³, Becki Cleveland¹, Shruti Saxena Beem⁴, Tessa Englund⁵, Claire Timon⁴ and Saira Sheikh⁵, ¹University of North Carolina, Chapel Hill, NC, ²UNC Health, Chapel Hill, NC, ³University of North Carolina, Chapel Hill, ⁴University of North Carolina at Chapel Hill, Chapel Hill, ⁵University of North Carolina at Chapel Hill, Chapel Hill, NC
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, multi-system autoimmune disease with heterogenous presentation. Most patients with SLE report fatigue or brain fog, which often…
Abstract Number: 1071 • ACR Convergence 2025
Depression and Mental Health Service Gaps in Autoimmune Disease: Insights from a Simulated BRFSS Dataset
Malay Rathod¹, Shivani Modi², Veera Durga Vaishnavi Kurra³, Karan Yagnik⁴ and Doantrnag Du⁴, ¹Monmouth Medical Center, Ewing, NJ, ²Jefferson Einstein Montgomery Hospital, Ewign, NJ, ³University of Oklahoma Health Sciences Center, Oklahoma City, OK, ⁴Monmouth Medical Center, Long Branch, NJ
Background/Purpose: Autoimmune diseases are complex conditions that may predispose individuals to an increased mental health burden, including depression. The immune system leads to inflammation in…
Abstract Number: 2254 • ACR Convergence 2025
Association of disease activity with insomnia, depression, and fatigue in patients with rheumatoid arthritis: a multicenter prospective observational study
Misako Higashida-Konishi¹, Keisuke Izumi², Shuntaro Saito Saito³, Hiroki Tabata⁴, Satoshi Hama⁴, Tatsuhiro Oshige⁴, Yutaka Okano⁴, Hisaji Oshima⁴, Katsuya Suzuki⁴, Jiro Sakamoto⁵, Toshikazu Fukami⁵, Kazumichi Minato⁵, Nobuhiko Kajio⁶, Yasushi Kondo³, Hiroaki Taguchi⁶ and Yuko Kaneko³, ¹NHO Tokyo Medical Center, Tokyo Meguroku, Japan, ²Division of Rheumatology, Department of Medicine, NHO Tokyo Medical Center/Keio University School of Medicine/TechDoctor, Inc., Tokyo, Japan, ³Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, ⁴Division of Rheumatology, Department of Medicine, NHO Tokyo Medical Center, Tokyo, Japan, ⁵TechDoctor, Inc., Tokyo, Japan, ⁶Department of Rheumatology, Kawasaki Municipal Hospital, Kanagawa, Japan
Background/Purpose: Patients with rheumatoid arthritis (RA) often experience not only joint-related symptoms but also systemic issues such as insomnia, depression, and fatigue [1–3]. These symptoms…
Abstract Number: 1058 • ACR Convergence 2025
Prevalence of Depression Associated with Rheumatologic Medications with Labeled Warnings: Real World Evidence from a Tertiary Care Center
Cassandra Dolecki¹, Sama Hajizadeh¹, Yue Yin² and Adam Dore¹, ¹Allegheny Health Network, Pittsburgh, PA, ²Allegheny Health Network, Pittsburgh
Background/Purpose: The prevalence of depression in patients who have rheumatic diseases is high and has been shown to be associated with poorer outcomes. Additionally, certain…
Abstract Number: 2243 • ACR Convergence 2025
Differences In GDF-15 Levels In Rheumatoid Arthritis Patients With Remission Or Mild Disease Activity Are Associated With Fewer Depressive Symptoms: Clinical Data And Bioinformatic Analysis
Jessica Roldan Ortega¹, Mario Peña², Evelyn Aranda Cano³, Luz Viruel⁴, Itzel Palafox Sosa⁵, David Vera Bustamante⁶, Fausto Sanchez-Muñoz², Yaneli Juarez-Vicuña⁷ and Laura Aline Martinez-Martinez⁸, ¹INSTITUTO NACIONAL DE CARDIOLOGIA, Ciudad de México, Federal District, Mexico, ²Instituto Nacional de Cardiologia Ignacio Chavez, Mexico city, Mexico, ³Departament of rheumatology Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de Mexico, Federal District, Mexico, ⁴Universidad Autónoma del Estado de Hidalgo, Tula de Allende, Hidalgo, Mexico, ⁵Escuela Superior de Medicina-Instituto Politècnico Nacional, ciudad de mexico, Federal District, Mexico, ⁶Benemérita Universidad Autónoma de Puebla, Heroica Puebla de Zaragoza, Puebla, Mexico, ⁷Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico, Mexico City, Mexico, ⁸Rheumatology Department at National Institute of Cardiology Ignacio Chávez, Mexico City, Federal District, Mexico
Background/Purpose: Depression is a common comorbidity in rheumatoid arthritis patients and has a significant effect on the disease course. [Brock J, et al. Nat Rev…
Abstract Number: 1022 • ACR Convergence 2025
Abuse in Rheumatic Diseases: Associations with Depression, Disability, and Psychosocial Risk Factors
Margarita Isabel Alarcon-Jarquin¹, Egla Samantha Sanchez-Peralta², Maria Eugenia Corral-Trujillo³, Daniela Alejandra Salcedo-Soto⁴, Judith Michelle Ramirez-Alonso⁴, Ana Elena González-Rosales⁵, Juan Daniel Valdez-Cruz⁴, Osmel Adrián Ramirez-Uzcategui⁴, Jesús Gilberto Espinoza-Gámez⁶, Yessica Rubi Reyes-Yepiz¹⁴, Juan Pablo González-Morales⁴, Virginia Pascual-Ramos⁷, Dionicio A. Galarza-Delgado⁸, Gabriel Figueroa-Parra⁹ and Diana E. Flores-Alvarado², ¹Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, ²Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, México, Monterrey, Nuevo Leon, Mexico, ³Universidad Autónoma de Nuevo León, Rheumatology Service, Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo León, México., Monterrey, Nuevo Leon, Mexico, ⁴Hospital universitario José Eleuterio González, Monterrey, Nuevo Leon, Mexico, ⁵Hospital universitario José Eleuterio González, Monterrey, Mexico, ⁶Rheumatology Service, Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo Leon, Mexico, ⁷Rheumatology Service, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico, Mexico City, Distrito Federal, Mexico, ⁸Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico, ⁹Rheumatology Service, Hospital Universitario “Dr. Jose Eleuterio Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico
Background/Purpose: Exposure to a hostile environment may negatively impact disease outcomes in patients with RD, particularly by affecting their mental health and overall quality of…
Abstract Number: 2202 • ACR Convergence 2025
Epidemiologic Evaluation of Postpartum Mental Health for Women Living with Systemic Lupus Erythematosus: A Population-Based Cohort Study Among Medicaid Enrollees
Alyssa Howren¹, Amadeia Rector², Sadaf Sediqi³ and Julia F Simard⁴, ¹Stanford University, Menlo Park, CA, ²Stanford University, San Francisco, CA, ³Stanford University, Palo Alto, CA, ⁴Stanford Medicine, Stanford, CA
Background/Purpose: Systemic lupus erythematosus (SLE) is a multisystem autoimmune rheumatic disease, predominately affecting women during their reproductive years. Despite widespread evidence that individuals with SLE…
Abstract Number: 0714 • ACR Convergence 2025
Factors Associated With Depression And Anxiety In ANCA-Associated Vasculitis Patients: Data From The Almenara Vasculitis Cohort
Alvaro Oyarce-Calderón¹, Allison Figueroa-Sánchez², Leonor León-Yaurimucha², Rocío Gamboa-Cárdenas³, Zoila Rodríguez-Bellido⁴, Risto Perich-Campos⁵, Graciela Alarcón⁶, Manuel Ugarte-Gil⁷ and Victor Pimentel-Quiroz⁸, ¹Hospital Nacional Guillermo Almenara Irigoyen, San Miguel, Lima, Peru, ²Universidad Científica del Sur, Lima, Peru, ³Universidad Científica del Sur, Lima, Peru, ⁴Hospital Nacional Guillermo Almenara Irigoyen; Universidad Nacional Mayor de San Marcos, Lima, Peru, ⁵Hospital Nacional Guillermo Almenara Irigoyen; Universidad Nacional Mayor de San Marcos, La Molina, Peru, ⁶The University of Alabama at Birmingham, Oakland, CA, ⁷Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur, Lima, Peru; Hospital Guillermo Almenara Irigoyen, EsSalud, Lima, Peru, Lima, Peru, ⁸Universidad Científica del Sur, San Isidro, Peru
Background/Purpose: Depression and anxiety symptoms have been reported in 28% of patients suffering from vasculitides. However, in patients with ANCA-associated vasculitis (AAV), their frequency and…
Abstract Number: 2079 • ACR Convergence 2025
Association Between Symptomatic Knee Osteoarthritis and Health-Related Quality of Life in Individuals with Type 2 Diabetes: A Cross-Sectional Study
Abdalmohsen Almodahka¹, Alanna Weisman², Baiju Shah³, Tristan Watson⁴, Ian stanaitis⁵, Amish Parikh⁶, Robert Goldberg⁶, Lorraine Lipscombe⁷, Gillian Hawker¹ and Lauren King¹, ¹University of Toronto, Toronto, ON, Canada, ²University Health Network Toronto General Hospital Site/Sinai Health System, Toronto, ON, Canada, ³Sunnybrook Health Sciences Centre, Toronto, ON, Canada, ⁴Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, ⁵Research and Innovation Institute, Women’s College Hospital, Toronto, ON, Canada, Toronto, ON, Canada, ⁶Division of Endocrinology, Department of Medicine, Trillium Health Partners, Mississauga, ON, Canada, Toronto, ON, Canada, ⁷Department of Medicine, University of Toronto, Research and Innovation Institute, Women’s College Hospital, Toronto, ON, Canada, Toronto, ON, Canada
Background/Purpose: Knee osteoarthritis (OA) and type 2 diabetes (T2D) commonly coexist, but their combined impact on health-related quality of life (HRQoL) remains understudied. Our objective…
Abstract Number: 0770 • ACR Convergence 2025
Interrelationships of Depression, Pain, and Gait Mechanics and their Associations with Physical Activity Levels Among People with Knee Osteoarthritis
Oiza Peters, Steven Garcia, Joy Itodo, Ogundoyin Ogundiran and kharma Foucher, UNIVERSITY OF ILLINOIS, CHICAGO, Chicago, IL
Background/Purpose: Depression is associated with low physical activity (PA) levels in people with knee osteoarthritis (KOA)1. Pain contributes to both depression and PA levels in…
Abstract Number: 2040 • ACR Convergence 2025
Steroid Psychosis and Neuropsychiatric Symptoms induced by Corticosteroid Injection in Rheumatology Patients
Morvarid Kavosh¹, Virva Walkington¹, Jigisha Rakholiya¹, Krystle Tapia², Maheswari Muruganandam¹, N. Suzanne Emil¹, Frank O'Sullivan³ and Wilmer Sibbitt¹, ¹University of New Mexico, Albuquerque, NM, ²University of New Mexico Hospital, Albuquerque, NM, ³University of New Mexico, Albuquerque
Background/Purpose: Musculoskeletal (MS) corticosteroid (CS) injections are commonly used for joint inflammation with a perceived low risk of systemic toxicity, including hyperglycemia and adrenal suppression.…
Abstract Number: 0365 • ACR Convergence 2025
Clinical Characteristics and Psychosocial Outcomes of Patients with UCTD Compared to SLE
Caroline Siegel¹, Yongjay Kim², Lucy Masto³, Neha Nagpal¹, Amaya Smole⁴, Dongmei Sun¹, Haley Slosberg¹, Margaret Minett⁵, Joann Vega¹, Deanna Jannat-Khah¹, Jane Salmon¹, Michael Lockshin⁶, Lisa Sammaritano¹ and Medha Barbhaiya¹, ¹Hospital for Special Surgery, New York, NY, ²Hospital for Special Surgery, Englewood Cliffs, NJ, ³Hospital for Special Surgery, San Francisco, CA, ⁴Hospital for Special Surgery, Brooklyn, NY, ⁵Hospital for Special Surgery, New York, ⁶Hospital for Special Surgery, Weill Cornell Medicine, New York, NY
Background/Purpose: While UCTD is considered less clinically severe than SLE, our prior qualitative study reported that patients with UCTD experience significant psychosocial challenges (J Clin…
Abstract Number: 1976 • ACR Convergence 2025
Implementing a Change Package for Depression Screening and Appropriate Response for Children with Rheumatic Disease
Emily Vara¹, Mileka Gilbert¹, Kelly Rouster-Stevens², Talia Buitrago-Mogollon³, Sarah Mabus³, Justin Moore⁴ and Sheetal Vora⁵, ¹Medical University of South Carolina, Charleston, SC, ²Emory University/Children's Healthcare of Atlanta, Peachtree Corners, GA, ³Atrium Health Levine Children’s Center for Advancing Pediatric Excellence, Charlotte, NC, ⁴Wake Forest School of Medicine, Winston Salem, NC, ⁵Atrium Health Levine Children's Hospital, Charlotte, NC
Background/Purpose: Children with rheumatic diseases (RD) are at increased risk for developing mental health (MH) issues, including depression, which can negatively impact disease outcomes. MH…
Abstract Number: 0225 • ACR Convergence 2025
Positive anxiety, depression and/or fibromyalgia screening on validated MDHAQ indices is seen in 30-50% of routine care patients with all rheumatic diagnoses
Juan Schmukler¹, Tengfei Li² and Theodore Pincus¹, ¹Rush University Medical Center, Chicago, IL, ²Rush, chicago, IL
Background/Purpose: Comorbid anxiety (ANX), depression (DEP), and fibromyalgia(FM) are reported as more common in patients with rheumatoid arthritis (RA) and other rheumatic diagnoses than in…
Abstract Number: 1688 • ACR Convergence 2025
Impact of Stress, Anxiety, and Depression on Fatigue as moderated by Resilience and Exposure to Trauma in Rheumatology Patients
Akhila Veeravalli¹, Sankeerthana gajjala² and Sarath Chandra Mouli Veeravalli³, ¹Department of Rheumatology, KIMS Hospitals, Secuderabad, India, Hyderabad, Telangana, India, ²KIMS Hospitals, Secunderabad, India, Hyderabad, Telangana, India, ³Dept. of Rheumatology and Clinical Immunology, KIMS Hospitals, Secunderabad, India, Hyderabad, Telangana, India
Background/Purpose: This study aimed to examine the impact of psychological distress—specifically stress, anxiety, and depression—on fatigue in rheumatology patients, and explored how this relationship is…

1
2
3
…
17
Next Page »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].